Exposure to secondhand and thirdhand smoke in private vehicles: Measurements in air and dust samples
Por:
Continente X., Henderson E., López-González L., Fernández E., Tigova O., Semple S., O'Donnell R., Navas-Acién A., Cortés-Francisco N., Ramírez N., Dobson R., López M.J., Castellano Y., Fu M., Ballbè M., Amalia B., Arechavala T., Gallus S., Lugo A., Liu X., Borroni E., Stival C., Colombo P., Clancy L., Keogan S., Byrne H., Behrakis P., Tzortzi A., Vardavas C., Vyzikidou V.K., Bakelas G., Mattiampa G., Boffi R., Ruprecht A., De Marco C., Borgini A., Veronese C., Bertoldi M., Tittarelli A., Gorini G., Carreras G., Cortini B., Verdi S., Lachi A., Chellini E., López Nicolás Á., Trapero-Bertran M., Celdrán Guerrero D., Radu-Loghin C., Nguyen D., Starchenko P., Soriano J.B., Ancochea J., Alonso T., Pastor M.T., Erro M., Roca A., Pérez P., Castillo E.G.
Publicada:
18 jul 2023
Ahead of Print:
18 jul 2023
Resumen:
BACKGROUND: This study aimed to estimate airborne nicotine concentrations and nicotine, cotinine, and tobacco-specific nitrosamines (TSNAs) in settled dust from private cars in Spain and the UK. METHODS: We measured vapor-phase nicotine concentrations in a convenience sample of 45 private cars from Spain (N = 30) and the UK (N = 15) in 2017-2018. We recruited non-smoking drivers (n = 20), smoking drivers who do not smoke inside the car (n = 15), and smoking drivers who smoke inside (n = 10). Nicotine, cotinine, and three TSNAs (NNK, NNN, NNA) were also measured in settled dust in a random subsample (n = 20). We computed medians and interquartile ranges (IQR) of secondhand smoke (SHS) and thirdhand smoke (THS) compounds according to the drivers' profile. RESULTS: 24-h samples yielded median airborne nicotine concentrations below the limit of quantification (LOQ) (IQR:
Filiaciones:
Continente X.:
Agència de Salut Pública de Barcelona, Pl. Lesseps, 1, Barcelona, 08023, Spain
Centre for Biomedical Research in Epidemiology and Public Health (CIBERESP), Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0, Madrid, 28029, Spain
Sant Pau Institute of Biomedical Research (IIB Sant Pau), Sant Antoni Maria Claret, 167, Barcelona, 08025, Spain
Henderson E.:
Agència de Salut Pública de Barcelona, Pl. Lesseps, 1, Barcelona, 08023, Spain
Sant Pau Institute of Biomedical Research (IIB Sant Pau), Sant Antoni Maria Claret, 167, Barcelona, 08025, Spain
Public Health Agency of Barcelona (ASPB), Spain
López-González L.:
Agència de Salut Pública de Barcelona, Pl. Lesseps, 1, Barcelona, 08023, Spain
Fernández E.:
Unitat de Control de Tabac, Institut Català d'Oncologia, Av. Granvia de l'Hospitalet 199-203, L'Hospitalet de Llobregat, 08908, Spain
Institut D'Investigació Biomèdica de Bellvitge, Av. Granvia de l'Hospitalet 199, L'Hospitalet de Llobregat, 08908, Spain
Department of Clinical Sciences, Campus de Bellvitge, School of Medicine and Health Sciences, University of Barcelona, Feixa Llarga, S/n, L'Hospitalet de Llobregat, 08907, Spain
Centre for Biomedical Research in Respiratory Diseases (CIBERES), Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0, Madrid, 28029, Spain
Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
Tigova O.:
Unitat de Control de Tabac, Institut Català d'Oncologia, Av. Granvia de l'Hospitalet 199-203, L'Hospitalet de Llobregat, 08908, Spain
Institut D'Investigació Biomèdica de Bellvitge, Av. Granvia de l'Hospitalet 199, L'Hospitalet de Llobregat, 08908, Spain
Department of Clinical Sciences, Campus de Bellvitge, School of Medicine and Health Sciences, University of Barcelona, Feixa Llarga, S/n, L'Hospitalet de Llobregat, 08907, Spain
Centre for Biomedical Research in Respiratory Diseases (CIBERES), Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0, Madrid, 28029, Spain
Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
Semple S.:
Institute for Social Marketing, University of Stirling, Scotland, Stirling, FK9 4LA, United Kingdom
University of Stirling (UNISTIR), United Kingdom
O'Donnell R.:
Institute for Social Marketing, University of Stirling, Scotland, Stirling, FK9 4LA, United Kingdom
University of Stirling (UNISTIR), United Kingdom
Navas-Acién A.:
Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, 722 W 168th St, New York, NY 10032, United States
Cortés-Francisco N.:
Agència de Salut Pública de Barcelona, Pl. Lesseps, 1, Barcelona, 08023, Spain
Centre for Biomedical Research in Epidemiology and Public Health (CIBERESP), Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0, Madrid, 28029, Spain
Sant Pau Institute of Biomedical Research (IIB Sant Pau), Sant Antoni Maria Claret, 167, Barcelona, 08025, Spain
Ramírez N.:
Institut d'Investigació Sanitària Pere Virgili, Dr. Mallafré Guasch, 4, Tarragona, 43007, Spain
Universitat Rovira i Virgili, Department of Electronic Engineering, Escorxador, s/n, Tarragona, 43003, Spain
Centre for Biomedical Research in Diabetes and Associated Metabolic Diseases (CIBERDEM), Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0, Madrid, 28029, Spain
Dobson R.:
Institute for Social Marketing, University of Stirling, Scotland, Stirling, FK9 4LA, United Kingdom
University of Stirling (UNISTIR), United Kingdom
López M.J.:
Agència de Salut Pública de Barcelona, Pl. Lesseps, 1, Barcelona, 08023, Spain
Centre for Biomedical Research in Epidemiology and Public Health (CIBERESP), Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0, Madrid, 28029, Spain
Sant Pau Institute of Biomedical Research (IIB Sant Pau), Sant Antoni Maria Claret, 167, Barcelona, 08025, Spain
Departament de Ciències Experimentals i de la Salut (DCEXS), Universitat Pompeu Fabra, Doctor Aiguader, 88, Barcelona, 08003, Spain
Public Health Agency of Barcelona (ASPB), Spain
Castellano Y.:
Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
Fu M.:
Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
Ballbè M.:
Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
Amalia B.:
Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Spain
Arechavala T.:
Public Health Agency of Barcelona (ASPB), Spain
Gallus S.:
Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Italy
Lugo A.:
Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Italy
Liu X.:
Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Italy
Borroni E.:
Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Italy
Stival C.:
Istituto di Ricerche Farmacologiche Mario Negri IRCCS (IRFMN), Italy
Colombo P.:
Istituto DOXA, Worldwide Independent Network/Gallup International Association, Italy
Clancy L.:
TobaccoFree Research Institute Ireland (TFRI), Ireland
Keogan S.:
TobaccoFree Research Institute Ireland (TFRI), Ireland
Byrne H.:
TobaccoFree Research Institute Ireland (TFRI), Ireland
Behrakis P.:
Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
Tzortzi A.:
Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
Vardavas C.:
Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
Vyzikidou V.K.:
Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
Bakelas G.:
Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
Mattiampa G.:
Hellenic Cancer Society - George D. Behrakis Research Lab (HCS), Greece
Boffi R.:
Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Italy
Ruprecht A.:
Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Italy
De Marco C.:
Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Italy
Borgini A.:
Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Italy
Veronese C.:
Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Italy
Bertoldi M.:
Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Italy
Tittarelli A.:
Fondazione IRCCS Istituto Nazionale Dei Tumori (INT), Italy
Gorini G.:
Istituto per Lo Studio, La Prevenzione, e La Rete Oncologica (ISPRO), Italy
Carreras G.:
Istituto per Lo Studio, La Prevenzione, e La Rete Oncologica (ISPRO), Italy
Cortini B.:
Istituto per Lo Studio, La Prevenzione, e La Rete Oncologica (ISPRO), Italy
Verdi S.:
Istituto per Lo Studio, La Prevenzione, e La Rete Oncologica (ISPRO), Italy
Lachi A.:
Istituto per Lo Studio, La Prevenzione, e La Rete Oncologica (ISPRO), Italy
Chellini E.:
Istituto per Lo Studio, La Prevenzione, e La Rete Oncologica (ISPRO), Italy
López Nicolás Á.:
Polytechnic University of Cartagena (UPCT), Spain
Trapero-Bertran M.:
Polytechnic University of Cartagena (UPCT), Spain
Celdrán Guerrero D.:
Polytechnic University of Cartagena (UPCT), Spain
Radu-Loghin C.:
European Network on Smoking and Tobacco Prevention (ENSP), Belgium
Nguyen D.:
European Network on Smoking and Tobacco Prevention (ENSP), Belgium
Starchenko P.:
European Network on Smoking and Tobacco Prevention (ENSP), Belgium
Soriano J.B.:
Hospital Universitario La Princesa (IISP), Spain
Ancochea J.:
Hospital Universitario La Princesa (IISP), Spain
Alonso T.:
Hospital Universitario La Princesa (IISP), Spain
Pastor M.T.:
Hospital Universitario La Princesa (IISP), Spain
Erro M.:
Hospital Universitario La Princesa (IISP), Spain
Roca A.:
Hospital Universitario La Princesa (IISP), Spain
Pérez P.:
Hospital Universitario La Princesa (IISP), Spain
Castillo E.G.:
Hospital Universitario La Princesa (IISP), Spain
Green Published, hybrid, All Open Access; Hybrid Gold
|